Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

A 91-year-old woman affected with acquired Von Willebrand (VW) syndrome and intestinal angiodysplasias presented with severe gastrointestinal bleeding (hemoglobin 5 g/dl). Despite replacement therapy with VW factor/factor VIII concentrate qid, bleeding did not stop (eleven packed red blood cell units were transfused over three days). High circulating levels of anti-VW factor immunoglobulin M were documented immunoenzimatically. Heart ultrasound showed abnormalities of the mitral and aortic valves with severe flow alterations. When intravenous immunoglobulins were added to therapy, prompt clinical and laboratory responses occurred: complete cessation of bleeding, raise in hemoglobin, VW factor antigen, VW ristocetin cofactor and factor VIII levels as well as progressive reduction of the anti-VWF autoantibody levels.

Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding / M. Cugno, A. Tedeschi, S.M. Siboni, F. Stufano, F. Depetri, F.M. Franchi, S. Griffini, F. Peyvandi. - In: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. - ISSN 2162-3619. - 3:1(2014), pp. 15.1-15.6. [10.1186/2162-3619-3-15]

Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding

M. Cugno
Primo
;
S.M. Siboni;F. Depetri;S. Griffini
Penultimo
;
F. Peyvandi
Ultimo
2014

Abstract

A 91-year-old woman affected with acquired Von Willebrand (VW) syndrome and intestinal angiodysplasias presented with severe gastrointestinal bleeding (hemoglobin 5 g/dl). Despite replacement therapy with VW factor/factor VIII concentrate qid, bleeding did not stop (eleven packed red blood cell units were transfused over three days). High circulating levels of anti-VW factor immunoglobulin M were documented immunoenzimatically. Heart ultrasound showed abnormalities of the mitral and aortic valves with severe flow alterations. When intravenous immunoglobulins were added to therapy, prompt clinical and laboratory responses occurred: complete cessation of bleeding, raise in hemoglobin, VW factor antigen, VW ristocetin cofactor and factor VIII levels as well as progressive reduction of the anti-VWF autoantibody levels.
Acquired von Willebrand syndrome; gastrointestinal bleeding; intravenous immunoglobulin
Settore MED/09 - Medicina Interna
2014
Article (author)
File in questo prodotto:
File Dimensione Formato  
2162-3619-3-15.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 441.22 kB
Formato Adobe PDF
441.22 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/253336
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? ND
social impact